A study revealed that IFNγ derived from immunotherapy-activated CD8+ T cells act synergistically with radiotherapy to inhibit SLC7A11 which results in reduced cystine uptake, and increased tumor lipid oxidation and ferroptosis, thereby tumor suppression [166]. The gene discussed is SLC7A11; the disease is neoplasm.